Back to News
Market Impact: 0.18
Pulse Biosciences Consensus Price Target Increased 12.27% to $51.82
Source: Nasdaq
Analyst EstimatesHealthcare & Biotech
The average 12-month analyst price target for Pulse Biosciences was raised 12.27% to $51.82 per share from $46.16 as of August 25, 2026. The revision indicates improved analyst valuation expectations, though it reflects aggregate consensus targets rather than a company operating update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
PLSE0.32
More News
- DST Global Advisors, 10% owner, sells $109.3m Chime stock
- DST Global Advisors sells $109.3m in Chime Financial shares
- Premarket movers: Intel jumps on SK Hynix memory-chip talks, J.B. Hunt slides
- AI-Fueled Profit Growth Set to Flow Through Every S&P 500 Sector
- Snowflake SVP Vivek Raghunathan sells $1.23m in company stock
- Japan has a problematic age gap: 100,000-plus residents are over 100 and the pension system is buckling